121 related articles for article (PubMed ID: 2155039)
1. Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats.
Islam AK; Bodnar RJ
Brain Res; 1990 Feb; 508(2):293-6. PubMed ID: 2155039
[TBL] [Abstract][Full Text] [Related]
2. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions.
Arjune D; Standifer KM; Pasternak GW; Bodnar RJ
Brain Res; 1990 Dec; 535(1):101-9. PubMed ID: 1963340
[TBL] [Abstract][Full Text] [Related]
3. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.
Stein JA; Znamensky V; Baumer F; Rossi GC; Pasternak GW; Bodnar RJ
Brain Res; 2000 May; 864(2):240-51. PubMed ID: 10802031
[TBL] [Abstract][Full Text] [Related]
4. Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine.
Arjune D; Bodnar RJ
Brain Res; 1990 Nov; 534(1-2):313-6. PubMed ID: 1963562
[TBL] [Abstract][Full Text] [Related]
5. Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor.
Arjune D; Bowen WD; Bodnar RJ
Pharmacol Biochem Behav; 1991 Jun; 39(2):429-36. PubMed ID: 1658817
[TBL] [Abstract][Full Text] [Related]
6. Central opioid receptor subtype mediation of isoproterenol-induced drinking in rats.
Glass MJ; Hahn B; Joseph A; Bodnar RJ
Brain Res; 1994 Sep; 657(1-2):310-4. PubMed ID: 7820634
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.
Kelley AE; Bless EP; Swanson CJ
J Pharmacol Exp Ther; 1996 Sep; 278(3):1499-507. PubMed ID: 8819538
[TBL] [Abstract][Full Text] [Related]
8. Effects of parabrachial opioid antagonism on stimulation-induced feeding.
Carr KD; Aleman DO; Bak TH; Simon EJ
Brain Res; 1991 Apr; 545(1-2):283-6. PubMed ID: 1650277
[TBL] [Abstract][Full Text] [Related]
9. Mediation of insulin hyperphagia by specific central opiate receptor antagonists.
Beczkowska IW; Bodnar RJ
Brain Res; 1991 May; 547(2):315-8. PubMed ID: 1653080
[TBL] [Abstract][Full Text] [Related]
10. Effects of beta-funaltrexamine on ingestive behaviors in the rat.
Ukai M; Holtzman SG
Eur J Pharmacol; 1988 Aug; 153(2-3):161-5. PubMed ID: 2846315
[TBL] [Abstract][Full Text] [Related]
11. Interaction between opioid antagonists and amphetamine: evidence for mediation by central delta opioid receptors.
Jones DN; Holtzman SG
J Pharmacol Exp Ther; 1992 Aug; 262(2):638-45. PubMed ID: 1323656
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists.
Baumann MH; Rabii J
Brain Res; 1991 Dec; 567(2):224-30. PubMed ID: 1667901
[TBL] [Abstract][Full Text] [Related]
13. Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats.
Koch JE; Bodnar RJ
Brain Res; 1994 Sep; 657(1-2):191-201. PubMed ID: 7820618
[TBL] [Abstract][Full Text] [Related]
14. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats.
Cole JL; Leventhal L; Pasternak GW; Bowen WD; Bodnar RJ
Brain Res; 1995 Apr; 678(1-2):168-76. PubMed ID: 7620885
[TBL] [Abstract][Full Text] [Related]
15. Analysis of central opioid receptor subtype antagonism of hypotonic and hypertonic saline intake in water-deprived rats.
Bodnar RJ; Glass MJ; Koch JE
Brain Res Bull; 1995; 36(3):293-300. PubMed ID: 7697383
[TBL] [Abstract][Full Text] [Related]
16. Beta-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Silva RM; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2001 May; 297(2):590-6. PubMed ID: 11303047
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.
Silva RM; Grossman HC; Hadjimarkou MM; Rossi GC; Pasternak GW; Bodnar RJ
J Pharmacol Exp Ther; 2002 May; 301(2):513-8. PubMed ID: 11961051
[TBL] [Abstract][Full Text] [Related]
18. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
Dray A; Nunan L; Wire W
Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
[TBL] [Abstract][Full Text] [Related]
19. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.
Makino M; Kitano Y; Komiyama C; Hirohashi M; Takasuna K
Br J Pharmacol; 2000 Jul; 130(6):1269-74. PubMed ID: 10903965
[TBL] [Abstract][Full Text] [Related]
20. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
Adams JU; Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
